MIT Sloan 2014 BioInnovations Conference: Precision Medicine & the Impact of Innovation on Targeted Care
Friday, February 28 2014
8:00 am – 6:30 pm
This event was posted by Massachusetts Institute of Technology
Location: Boston Marriott Cambridge Hotel, Cambridge MA
The MIT Sloan BioInnovations conference has established itself as an engaging forum for leaders in industry, academia, and policy to discuss current issues and future innovations in healthcare and life sciences.
This year, the BioInnovations conference focuses on the trend of precision medicine in the healthcare industry. Innovations in genomics technology have made the genetic information of individuals very accessible, and that information is being used in a growing array of diagnostic and treatment-tuning capacities. We will explore the business opportunities in tracking and identifying particular genetic factors, as well as the role of genetic information in the development of new therapies. We will also explore how this trend impacts and is impacted by the regulatory and reimbursement environments in healthcare.
Join us for an all-day event featuring fantastic keynotes, interactive panel discussions, a poster session showcasing the latest start-ups and advances from academia, and opportunities to network with the healthcare and life sciences communities from Boston and beyond.
Dr Margaret A. Hamburg, M.D., Commissioner of the U.S. Food and Drug Administration
Dr George Church, Ph.D., Wyss Institute at Harvard University, & Director of Personal Genome Project
Mr Alex Azar, President, Eli Lilly USA, former Deputy Secretary of US Department of Health and Human Services
Mr Kieran Murphy, President, CEO of GE Healthcare Life Sciences